SEATTLE, Feb. 03, 2023 (GLOBE NEWSWIRE) -- #" Featured Image for Guides.Vote Featured Image for Guides.Vote
Zymeworks Announces China NMPA Acceptance of Biologics License Application for Zanidatamab for Second-Line Treatment of Biliary Tract Cancer 10-06-2024, 17:00